Takenaka T, Konda C, Sakano T, Shimoyama M, Kitahara T, Minato K, Watanabe S
Jpn J Clin Oncol. 1985 Jun;15(2):443-9.
We evaluated the occurrence and the type of second malignancies among 74 patients with Hodgkin's disease (HD) and 407 patients with non-Hodgkin's lymphoma (NHL) who were treated at the National Cancer Center Hospital for more than one year. Fifteen patients developed a second malignancy. In 10 of these patients the second cancer was gastric cancer, but no cases of acute nonlymphocytic leukemia were encountered. The observed number of second cancers in females among the HD patients was significantly (p less than 0.005) greater than the expected incidence based upon the number of age-adjusted person-years both for all cancers and for stomach cancer. However, no significant differences between males and females in the NHL patients were found. Furthermore, no significant differences were seen in any of the groups between the observed and expected numbers of second malignancies according to the treatment.
我们评估了在国立癌症中心医院接受治疗超过一年的74例霍奇金病(HD)患者和407例非霍奇金淋巴瘤(NHL)患者中第二原发性恶性肿瘤的发生率和类型。15例患者发生了第二原发性恶性肿瘤。其中10例患者的第二癌症为胃癌,但未发现急性非淋巴细胞白血病病例。HD患者中女性第二癌症的观察例数显著高于基于年龄调整人年数的所有癌症和胃癌的预期发病率(p<0.005)。然而,在NHL患者中未发现男性和女性之间存在显著差异。此外,根据治疗情况,各组中第二原发性恶性肿瘤的观察例数和预期例数之间均未发现显著差异。